Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. more
Time Frame | RGC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -3.26% | -2.82% | 0.15% |
1-Month Return | -13.27% | -4.22% | 1.78% |
3-Month Return | -1.96% | -9.52% | 8.7% |
6-Month Return | 15.09% | -3.45% | 12.24% |
1-Year Return | -47.16% | 5.62% | 30.9% |
3-Year Return | -80.08% | 3.8% | 30.19% |
5-Year Return | -47.71% | 39.68% | 91.72% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Cost of Revenue | 9.52K | 26.46K | 604.40K | 769.69K | 745.59K | [{"date":"2020-06-30","value":1.24,"profit":true},{"date":"2021-06-30","value":3.44,"profit":true},{"date":"2022-06-30","value":78.53,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":96.87,"profit":true}] |
Gross Profit | (9.52K) | (26.46K) | (604.40K) | (769.69K) | (745.59K) | [{"date":"2020-06-30","value":-951600,"profit":false},{"date":"2021-06-30","value":-2645600,"profit":false},{"date":"2022-06-30","value":-60439700,"profit":false},{"date":"2023-06-30","value":-76968700,"profit":false},{"date":"2024-06-30","value":-74558800,"profit":false}] |
Gross Margin | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Operating Expenses | 812.37K | 1.38M | 7.62M | 6.27M | 3.99M | [{"date":"2020-06-30","value":10.66,"profit":true},{"date":"2021-06-30","value":18.13,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":82.36,"profit":true},{"date":"2024-06-30","value":52.39,"profit":true}] |
Operating Income | (812.37K) | (1.38M) | (7.62M) | (6.27M) | (4.74M) | [{"date":"2020-06-30","value":-81237100,"profit":false},{"date":"2021-06-30","value":-138136200,"profit":false},{"date":"2022-06-30","value":-761777000,"profit":false},{"date":"2023-06-30","value":-627367100,"profit":false},{"date":"2024-06-30","value":-473672600,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Pre-Tax Income | (812.37K) | (1.35M) | (7.59M) | (6.06M) | (4.36M) | [{"date":"2020-06-30","value":-81237100,"profit":false},{"date":"2021-06-30","value":-134674500,"profit":false},{"date":"2022-06-30","value":-759455500,"profit":false},{"date":"2023-06-30","value":-606232900,"profit":false},{"date":"2024-06-30","value":-436322100,"profit":false}] |
Income Taxes | (1.00) | (210.10K) | (171.83K) | (191.20K) | 312.13K | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":-67.31,"profit":false},{"date":"2022-06-30","value":-55.05,"profit":false},{"date":"2023-06-30","value":-61.26,"profit":false},{"date":"2024-06-30","value":100,"profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Income From Continuous Operations | (812.37K) | (1.35M) | (7.59M) | (6.06M) | (4.36M) | [{"date":"2020-06-30","value":-81237100,"profit":false},{"date":"2021-06-30","value":-134674500,"profit":false},{"date":"2022-06-30","value":-759455500,"profit":false},{"date":"2023-06-30","value":-606232900,"profit":false},{"date":"2024-06-30","value":-436322100,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | (812.37K) | (1.35M) | (7.42M) | (5.87M) | (4.30M) | [{"date":"2020-06-30","value":-81237100,"profit":false},{"date":"2021-06-30","value":-134674500,"profit":false},{"date":"2022-06-30","value":-742272800,"profit":false},{"date":"2023-06-30","value":-587113000,"profit":false},{"date":"2024-06-30","value":-430183700,"profit":false}] |
EPS (Diluted) | (0.08) | - | - | - | - | [{"date":"2020-06-30","value":-8.3,"profit":false},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
RGC | |
---|---|
Cash Ratio | 41.13 |
Current Ratio | 41.92 |
Quick Ratio | 42.71 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RGC | |
---|---|
ROA (LTM) | -28.11% |
ROE (LTM) | -43.18% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RGC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.03 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.97 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RGC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 9.28 |
EV/R | 0.00 |
EV/Ebitda | NM |
Regencell Bioscience Holdings Ltd (RGC) share price today is $5.49
Yes, Indians can buy shares of Regencell Bioscience Holdings Ltd (RGC) on Vested. To buy Regencell Bioscience Holdings Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RGC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Regencell Bioscience Holdings Ltd (RGC) via the Vested app. You can start investing in Regencell Bioscience Holdings Ltd (RGC) with a minimum investment of $1.
You can invest in shares of Regencell Bioscience Holdings Ltd (RGC) via Vested in three simple steps:
The 52-week high price of Regencell Bioscience Holdings Ltd (RGC) is $19.1. The 52-week low price of Regencell Bioscience Holdings Ltd (RGC) is $3.03.
The price-to-earnings (P/E) ratio of Regencell Bioscience Holdings Ltd (RGC) is
The price-to-book (P/B) ratio of Regencell Bioscience Holdings Ltd (RGC) is 9.28
The dividend yield of Regencell Bioscience Holdings Ltd (RGC) is 0.00%
The market capitalization of Regencell Bioscience Holdings Ltd (RGC) is $76.26M
The stock symbol (or ticker) of Regencell Bioscience Holdings Ltd is RGC